While mouse studies have shown that loss of p85α results in increased sensitivity to insulin, defective platelet function, abnormal mast cell development, and increased production of IL-12 by dendritic cells, in the previous agammaglobulinemia patients, clinical consequences of the p85α defect have been relatively B cell-specific [3,13]. The gene discussed is INS; the disease is agammaglobulinemia.